Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morito Monden

Showing results (11-20 of 335) with videos related to

Pageof 34
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2003
[General surgery]Masato Sakon, Masataka Ikeda, Morito Monden
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 21, 2002
[Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy]Hiroaki Nagano, Masato Sakon, Morito Monden
Nihon Geka Gakkai Zasshi|April 24, 2002
[Molecular biology-based surgery for the future progress of cancer treatment]Yoshiyuki Fujiwara, Hirofumi Yamamoto, Morito Monden
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 20, 2007
Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinomaBazarragchaa Damdinsuren, Hiroaki Nagano, Morito Monden
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2003
[The chemotherapy for hepatocellular carcinoma]Hiroaki Nagano, Masato Sakon, Morito Monden
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 24, 2004
[Recent progress in chemotherapy for hepatocellular carcinoma]Masato Sakon, Hiroaki Nagano, Morito Monden
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|May 9, 2007
[Anti-tumor effect of interferon for hepatocellular carcinoma-from the clinical consideration]Hiroaki Nagano, Masato Sakon, Morito Monden
Cancer Science|June 10, 2008
Cancer cells survive with survivinHirofumi Yamamoto, Chew Yee Ngan, Morito Monden
Cancer Science|January 15, 2004
Adenovirus-mediated p53AIP1 gene transfer as a new strategy for treatment of p53-resistant tumorsKoji Yoshida, Morito Monden, Yusuke Nakamura, et al.
Surgery Today|March 2, 2002
Ischemia-reperfusion injury of the liver with special reference to calcium-dependent mechanismsMasato Sakon, Hideo Ariyoshi, Koji Umeshita, et al.
Pageof 34

Showing results (11-20 of 335) with videos related to

Sort By:
Pageof 34
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 28, 2003
[General surgery]Masato Sakon, Masataka Ikeda, Morito Monden
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 21, 2002
[Development and research of the new therapy for hepatocellular carcinoma--combined interferon and 5-fluorouracil therapy]Hiroaki Nagano, Masato Sakon, Morito Monden
Nihon Geka Gakkai Zasshi|April 24, 2002
[Molecular biology-based surgery for the future progress of cancer treatment]Yoshiyuki Fujiwara, Hirofumi Yamamoto, Morito Monden
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 20, 2007
Combined intra-arterial 5-fluorouracil and subcutaneous interferon-alpha therapy for highly advanced hepatocellular carcinomaBazarragchaa Damdinsuren, Hiroaki Nagano, Morito Monden
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2003
[The chemotherapy for hepatocellular carcinoma]Hiroaki Nagano, Masato Sakon, Morito Monden
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 24, 2004
[Recent progress in chemotherapy for hepatocellular carcinoma]Masato Sakon, Hiroaki Nagano, Morito Monden
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|May 9, 2007
[Anti-tumor effect of interferon for hepatocellular carcinoma-from the clinical consideration]Hiroaki Nagano, Masato Sakon, Morito Monden
Cancer Science|June 10, 2008
Cancer cells survive with survivinHirofumi Yamamoto, Chew Yee Ngan, Morito Monden
Cancer Science|January 15, 2004
Adenovirus-mediated p53AIP1 gene transfer as a new strategy for treatment of p53-resistant tumorsKoji Yoshida, Morito Monden, Yusuke Nakamura, et al.
Surgery Today|March 2, 2002
Ischemia-reperfusion injury of the liver with special reference to calcium-dependent mechanismsMasato Sakon, Hideo Ariyoshi, Koji Umeshita, et al.
Pageof 34